Clinical Trial Update: An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder [Phase 2]

View source ↗

Summary

An open-label, single-dose Phase 2 trial evaluating treatment for Alcohol Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: Beckley Psytech Limited | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED